Nonlinear Bioavailability of Metoclopramide in the Rat: Evidence for Saturable First-Pass Metabolism
Autor: | R. C. Ongley, John D. E. Price, R.P. Kapil, James E. Axelson |
---|---|
Rok vydání: | 1984 |
Předmět: |
Male
medicine.medical_specialty Metoclopramide Biological Availability Pharmaceutical Science Pharmacology Kidney chemistry.chemical_compound First pass effect In vivo Internal medicine medicine Animals Hepatectomy Lung Diazepam Carbon Tetrachloride Poisoning Rats Inbred Strains Metabolism Metoclopramide Hydrochloride Rats Bioavailability Kinetics medicine.anatomical_structure Endocrinology Liver chemistry Carbon tetrachloride medicine.drug |
Zdroj: | Journal of Pharmaceutical Sciences. 73:215-218 |
ISSN: | 0022-3549 |
DOI: | 10.1002/jps.2600730218 |
Popis: | In vivo and in vitro experiments were conducted in rats to examine the possibility of either extrahepatic metabolism or saturable first-pass effect as an explanation for the unusual presystemic clearance of metoclopramide (I) previously reported. In vivo studies involved two-thirds hepatectomized rats and animals pretreated with carbon tetrachloride to induce hepatic necrosis, whereas in vitro studies involved incubation of equal amounts of I (5.0 mumol/mL) with various tissue homogenates (viz., liver, kidney, and lung) or their 9000 X g supernatant fractions. Results suggest that the metabolism of I principally occurs in the rat liver, and there was no evidence suggesting the involvement of kidney or lung tissue in the metabolism of I. Forty-eight-hour cumulative urinary excretion studies following oral and intravenous administration of less than or equal to 5.0 mg/kg of metoclopramide hydrochloride were conducted. The bioavailability (F) values of I at dosage levels 0.1, 0.5, 1.0, and 5.0 mg/kg were 0.49, 0.75, 0.77, and 0.83, respectively. It is concluded that the liver is the primary organ for the metabolism of I in the rat and that the drug exhibits dose-dependent hepatic first-pass metabolism. |
Databáze: | OpenAIRE |
Externí odkaz: |